Intelligence · Clinical Development
Pipeline search results
Programs matching “breast-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 272 pipeline programs matching "breast-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
5-Fluorouracil
Hoffmann-La Roche
Breast Cancer
1 trial -
5-Fu/epirubicin/CTX following Docetaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
91782
Bayer HealthCare AG
Breast Cancer
1 trial -
Abemaciclib
Eli Lilly and Company
Breast Cancer
1 trial -
Abemaciclib
United Therapeutics Europe Ltd
Breast Cancer Female
1 trial -
Anastrozole
United Therapeutics Europe Ltd
Breast Cancer
2 trials -
Aromatase Inhibitors
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Aspirin
United Therapeutics Europe Ltd
Node Positive HER2 Negative Breast Cancer
1 trial -
Atezolizumab
Hoffmann-La Roche
Breast Cancer
1 trial -
B013+Nab-Paclitaxel
BRIGHT MINDS BIOSCIENCES INC.
Triple Negative Breast Cancer (TNBC)
1 trial -
BGB-43395
BEONE MEDICINES AUS PTY LTD
HR+/HER2- Breast Cancer
1 trial -
Bevacizumab
Hoffmann-La Roche
Breast Cancer
1 trial -
CMF regimen
United Therapeutics Europe Ltd
Breast Cancer
2 trials -
Carboplatin
Teva Pharma GmbH
Tubular Breast Cancer Stage II
1 trial -
Carboplatin
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Celecoxib
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dato-DXd
AstraZeneca
Breast Cancer
2 trials -
Faceptor
Biotech Pharmaceutical Co.,
Breast Cancer Metastatic
2 trials -
Fluzoparib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Metastatic
2 trials -
ForeCYTE Breast Aspirator
ATOSSA THERAPEUTICS, INC.
Breast Cancer, Preneoplastic Conditions, BRCA
1 trial -
Fulvestrant
Novartis Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Fulvestrant
Novartis Pharmaceuticals
Breast Cancer
1 trial -
Fulvestrant combined with Pyrotinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancer
1 trial -
HD201
Prestige Biopharma Belgium
HER2 Positive Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.